The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: In vivo evidence using a novel, selective, non-peptide CRF receptor antagonist

Brain Research

Volumn 770, Issue 1-2, 1997, Pages 89-95

  Baram, Tallie Z ^a   Chalmers, Derek T ^b   Chen, Chen ^b   Koutsoukos, Yani ^a   De Souza, Errol B ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

Corticotropin releasing factor; Corticotropin releasing factor receptor; Electroencephalogram; Limbic epilepsy; Seizure model; Selective antagonist

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR; NRI 27914; UNCLASSIFIED DRUG; UROCORTIN;

ANIMAL EXPERIMENT; ANTICONVULSANT THERAPY; ARTICLE; BRAIN DEVELOPMENT; COMPLEX PARTIAL SEIZURE; ELECTROENCEPHALOGRAM; EPILEPSY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC CORTEX; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL BEHAVIOR; BINDING COMPETITION; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; FEMALE; GROWTH, DEVELOPMENT AND AGING; LIMBIC SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; SEIZURE; SPRAGUE DAWLEY RAT; SUCKLING;

ANIMALS; ANIMALS, SUCKLING; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROENCEPHALOGRAPHY; FEMALE; INJECTIONS, INTRAPERITONEAL; LIMBIC SYSTEM; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SEIZURES;

EID: 0030609107     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00759-2     Document Type: Article

References (44)

1. Aldenhoff J.B., Gruol D.L., Rivier J., Vale W., Siggins G.R. Corticotropin-releasing factor decreases postburst hyperpolarization and excites hippocampal neurons. Science. 221:1983;875-877.
2. Avishai-Eliner S., Yi S.-J., Baram T.Z. Developmental profile of CRH-receptor messenger RNA in the rat limbic system. Dev. Brain Res. 91:1996;159-163.
3. Baram T.Z., Schultz L. CRH is a rapid and potent convulsant in the infant rat. Dev. Brain Res. 61:1991;97-101.
4. Baram T.Z., Hirsch E., Snead O.C. III, Schultz L. CRH induced seizures in the infant brain originate in the amygdala. Ann. Neurol. 31:1992;488-494.
5. Baram T.Z., Hirsch E., Schultz L. Short-interval amygdala kindling in neonatal rats. Dev. Brain Res. 73:1993;79-83.
6. Baram T.Z., Schultz L. Corticotropin releasing hormone receptor antagonist is effective for febrile seizures in the infant rat. Ann. Neurol. 36:1994;487.
7. Baram T.Z., Ribak C.E. Peptide-induced infant status epilepticus causes neuronal death and synaptic reorganization. NeuroReport. 6:1995;277-280.
8. Baram T.Z., Schultz L. ACTH does not control neonatal seizures induced by the administration of exogenous corticotropin releasing hormone. Epilepsia. 36:1995;174-178.
9. Baram T.Z., Avishai-Eliner S., Schultz L. Seizure threshold to kainic acid in infant rats is markedly decreased by corticotropin releasing hormone. Epilepsia. 36((Suppl.)):1995;. Abstr. B-05.
10. Baram T.Z., Koutsoukos Y., Schultz L., Rivier J. The effect of 'Astressin', a novel antagonist of corticotropin releasing hormone (CRH), on CRH-induced seizures in the infant rat: comparison with two other antagonists. Mol. Psychiatry. 1:1996;223-226.
11. Baram T.Z., Gerth A., Schultz L. Febrile seizures: an appropriate aged model suitable for long-term studies. Dev. Brain Res. 98:1997;170-265.
12. Behan D.P., Heinrichs S.C., Troncoso J.C., Liu X.J., Kawas C.H., Ling N., De Souza E.B. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease. Nature. 378:1995;284-287.
13. 1 mRNA expression. J Neurosci. 15:1995;6340-6350.
14. Chang C.P., Pearse R.V., O'Connell S., Rosenfeld M. Identification of a 7 transmembrane helix receptor for CRF and sauvagine in mammalian brain. Neuron. 11:1993;1187-1195.
15. Chen C., Dagnino R., De Souza E.B., Grigoriadis D.E., Huang C.Q., Kim K.-I., Liu Z., Moran T., Webb T.R., Witten J.P., Xie Y.F., McCarthy J.R. Design and synthesis of a series of non-peptide high affinity human corticotropin releasing factor-1 receptor antagonists. J. Med. Chem. 39:1996;4358-4360.
16. De Souza E.B., Insel T.R., Perrin M.H., Rivier J., Vale W.W., Kuhar M.J. Corticotropin-releasing factor receptors are widely distributed within the rat CNS: an autoradiographic study. J. Neurosci. 5:1985;3189-3203.
17. De Souza E.B., Whitehouse P.J., Kuhar M.J., Price D.L., Vale W.W. Reciprocal changes in corticotropin releasing factor (CRF)-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer disease. Nature. 319:1986;593-595.
18. Donaldson C.J., Sutton S.W., Perrin M.H., Corrigan A.Z., Lewis K.A., Rivier J.E., Vaughan J., Vale W.W. Cloning and characterization of human urocortin. Endocrinology. 137:1996;2167-2170.
19. Dunn A.J., Berridge C.W. Physiological and behavioral responses to corticotropin- releasing factor administration: is CRF a mediator of anxiety or stress response? Brain Res. Rev. 15:1990;71-100.
20. Ehlers C.L., Henriksen S.J., Wang M., Rivier J., Vale W.W., Kuhar M.J. Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats. Brain Res. 278:1983;332-336.
21. Fox E.A., Gruol D.L. CRF suppresses the afterhyperpolarization in cerebellar Purkinje neurons. Neurosci. Lett. 149:1993;103-107.
22. D.E. Grigoriadis, J.A. Heroux, E.B. De Souza, Characterization and regulation of corticotropin-releasing factor receptors in the central nervous, endocrine and immune systems, CRF: CIBA Found. Symp. 172, Wiley, NY, 1993, pp. 85-107.
23. Hung H.C., Chou C.-K.K., Chiu T.H., Lee E.H.Y. CRF increases protein phosphorylation and enhances retention performance in rats. NeuroReport. 3:1992;181-184.
24. Insel T.R., Battaglia G., Fairbanks D.W., De Souza E.B. The ontogeny of brain receptors for corticotropin-releasing factor and the development of their functional association with adenylate cyclase. J. Neurosci. 8:1988;4151-4158.
25. Koob G.F., Bloom F.E. Corticotropin releasing factor and behavior. Fed. Proc. 44:1985;259-263.
26. Lee E.H.Y., Hung H.C., Lu K.T., Chen W.H., Chen H.Y. Protein synthesis in the hippocampus associated with memory facilitation by CRF in rats. Peptides. 13:1992;927-927.
27. Lovenberg T.W., Liaw C.W., Grigoriadis D.E., Clevenger W., Chalmers D.T., De Souza E.B., Oltersdorf T. Cloning and characterization of functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc. Natl. Acad. Sci. USA. 92:1995;836-840.
28. 2 beta receptor mRNAs are differentially distributed between the rat central nervous system and peripheral tissues. Endocrinology. 136:1995;4139-4142.
29. Nemeroff C.B. New vistas in neuropeptide research in neuropsychiatry: focus on corticotropin releasing factor. Neuropsychopharmacology. 6:1992;69-75.
30. Perrin M.H., Donaldson C.J., Chen R., Lewis K.A., Vale W.W. Cloning and functional expression of a rat brain corticotropin releasing factor receptor. Endocrinology. 133:1993;3058-3061.
31. Pihoker C., Cain S.T., Nemeroff C.B. Postnatal development of regional binding of CRF and adenylate cyclase activity in the rat brain. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 16:1992;581-586.
32. Potter E., Sutton S., Donaldson C., Chen R., Perrin M.H., Lewis K., Sawchenko P.E., Vale W.W. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. USA. 91:1994;8777-8781.
33. Rivier J., Rivier C., Vale W. Synthetic competitive antagonists of corticotropin releasing factor: effect on ACTH secretion in the rat. Science. 224:1984;889-891.
34. P.E. Sawchenko, L.W. Swanson, Organization of CRF immunoreactive cells and fibers in the rat brain: immunohistochemical studies, in: E.B. De Souza, C.B. Nemeroff (Eds.), Corticotropin-releasing Factor: Basic and Clinical Studies of a Neuropeptide, CRC, Boca Raton, FL, 1990 pp. 29-46.
35. Smith B.N., Dudek F.E. Age-related epileptogenic effects of corticotropin releasing hormone in the isolated CA1 region of rat hippocampal slices. J. Neurophysiol. 72:1994;2328-2333.
36. Spina M., Merlo-Pich E., Chan R.K.W., Basso A.M., Rivier J., Vale W., Koob G.F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science. 273:1996;1561-1564.
37. Tsigos C., Chrousos G.P. Physiology of the hypothalamic pituitary adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. Endocrinol. Metab. Clin. North Am. 23:1994;451-466.
38. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 213:1981;1394-1397.
39. Vale W., Rivier C., Brown M.R., Spiess J., Koob G., Swanson L., Bilezikjian L., Bloom F., Rivier J. Chemical and biological characterization of corticotropin releasing factor. Recent Prog. Hormone Res. 39:1983;339-375.
40. Valentino R.J., Page M.E., Curtis A.L. Activation of noradrenergic locus ceruleus neurons by hemodynamic stress is due to local release of CRF. Brain Res. 555:1991;25-34.
41. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., Rivier J., Sawchenko P.E., Vale W. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin releasing factor. Nature. 378:1995;287-292.
42. Veldhuis D., de Wied D. Differential behavioral action of corticotropin releasing factor. Pharmacol. Biochem. Behav. 21:1984;707-713.
43. Watts A.G., Swanson L.W. Diurnal variation in the content of CRH-mRNA in the hypothalamic PVN of rats of both sexes as measured by ISH. Endocrinology. 125:1989;1734-1738.
44. Wong M.L., Licinio J., Gold P.W. Localization of CRH receptor mRNA in adult rat by ISH. Endocrinology. 135:1994;2275-2278.